Total trials
130
Active
16
Phase 3
10
Total enrollment
17,683
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Semaglutide 3.2 MG/ML | — | — | — | — | — | 1 |
Next readouts
- 2026-05-01
Top conditions
- Morbid Obesity10
- Obesity9
- Abdominal Aortic Aneurysm8
- Bariatric Surgery7
- Bariatric Surgery Candidate5
- Gastric Emptying3
- Obstructive Sleep Apnea3
- Chronic Obstructive Pulmonary Disease3
Frequently asked questions about Rijnstate Hospital
- How many clinical trials does Rijnstate Hospital have on ClinicalTrials.gov?
- Rijnstate Hospital is listed as the lead sponsor on 130 clinical trials in ClinicalTrials.gov, 16 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Rijnstate Hospital's trials are in Phase 3?
- 10 of Rijnstate Hospital's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Rijnstate Hospital focus on?
- Rijnstate Hospital's most-studied conditions on ClinicalTrials.gov are Morbid Obesity, Obesity, Abdominal Aortic Aneurysm, Bariatric Surgery, Bariatric Surgery Candidate.
- When are Rijnstate Hospital's next clinical trial readouts?
- Rijnstate Hospital has 1 upcoming primary-completion readout tracked here; the soonest is “DUTCH Weight Control in Atrial Fibrillation Study”, expected around 2026-05-01.